Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma
A new trial from Italy challenges a decades-old assumption that autologous stem cell transplant is more effective than radioimmunotherapy for consolidation after follicular lymphoma relapse.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
More News: Cancer & Oncology | Drugs & Pharmacology | Hematology | Italy Health | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants